Skip to content

S.C. Pharma

Active Private limited companyfounded 2018active for 8 yearsRue Planche Cabeille 84, 7370 DourKBO/BCE: BE 0700.951.989

Lifetime

7 annual accounts with figures on one time axis
peak of €54,811 in 2019
€15,021▲ 16.1%
lowest -€3,253 in 2024
-€1,401▲ €1,852
peak of €41,861 in 2023
€37,206▼ 3.6%
€15,676▼ 37.6%
Board1 name since 2018
1 director
Documentsfilings and deeds
17-06-202644 days before the deadline
2025micro format
Gross margin from €12,939 to €15,021Loss of €1,401Debts from €25,117 to €15,676Cash from €2,954 to €3,982

Key points

from the 2025 annual accounts

Losses

-€4,655 in two years
-3,2532024-1,4012025

The 2024 and 2025 financial years closed with a loss. 2024 was the heaviest.

Turnover

≈ €160,000 estimated

The micro format states no turnover.

Liquidity

0.98 was 0.43 in 2024

Short-term debts fell from €25,117 to €15,676.

Filings

7 annual accounts since 2019
AprilJune31 JulyOctober202020222024

The last five annual accounts were filed 33 to 53 days before the end of the period.

Position in the sector

70.4%

Higher solvency than 80% of companies in retail trade. Sector median 33.2% · 25,388 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 3,445 companies had the same profile as S.C. Pharma has now. Each dot stands for 9 companies, two years later.

90.0%
were still trading
7.6%
stopped another way
2.3%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a small loss

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 3,445 companies, not a prediction for S.C. Pharma. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 12-06-2023
  • all the sharesdeed of 19-06-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0700951989
changes role from manager to director holds all the shares · Legal-form conversion: from private limited company (pre-2019) to private limited company · Director discharge: · General meeting of 12-06-2023 · Gazette deed
Registered office moved from Mons to Blaugies The registered office moved from QUAI DES OTAGES 10 BТЕ 12, 7000 MONS to Rue Panche Cabeille 84, 7370 Blaugies · General meeting of 27-06-2022 · Gazette deed
Publication in the Belgian Official Gazette Gazette deed
All 15 events

Comparable companies

same main activity, similar in size and age
Company
S.C. Pharma Dour €52,882 €15,021 70.4% -
PRODENTAL GROUP Anderlecht €45,008 €14,379 -246.0% -
DOROTHEE VANDEVENNE Heusden-Zolder €64,554 €17,665 56.9% -
PHARMELLE Aalst €48,646 €13,408 21.4% -
LAPHARE Mettet €49,090 €11,181 52.2% -
LISCICOM Bruges €63,926 €20,130 71.3% -
Farma & zorg Aalst €74,440 €13,024 35.7% -

These companies have the same main activity as S.C. Pharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €45,000 and €74,400, founded between 2016 and 2020.

Official details

Source: KBO
Status
Active since 17-08-2018Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730and 2 others
Establishment unit
2.279.146.1477370 Dour, registered on 17-08-2018
Financial year end
31 December
Peppol
Reachable since 24-10-2025
Company details

Annual accounts 2025

€52,882▼ 17.0%
Filing
Filed on 17-06-2026, 44 days before the end of the filing period
Financials

Insights on S.C. Pharma

S.C. Pharma files the micro format. That format states no turnover. The gross margin fell from €54,811 in 2019 to €15,021 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about S.C. Pharma

What is the company number of S.C. Pharma?
The company number of S.C. Pharma is 0700.951.989. The VAT number is the same number with BE in front: BE 0700.951.989.
Where is S.C. Pharma based?
The registered office is at Rue Planche Cabeille 84, 7370 Dour.Company details
What does S.C. Pharma do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of S.C. Pharma?
S.C. Pharma is a private limited company (BV).
When was S.C. Pharma founded?
S.C. Pharma was founded on 17-08-2018.
Is S.C. Pharma still active?
Yes, S.C. Pharma is an active enterprise in the KBO register.
What is the turnover of S.C. Pharma?
The turnover in financial year 2025 is ≈ €160,000. This figure is estimated from the gross margin of €15,021 and 139 comparable companies (NACE 477). It probably lies between €58,000 and €340,000. It is a rough estimate. In financial year 2023 turnover was €80,854.Financials
Is S.C. Pharma profitable?
In financial year 2025, S.C. Pharma made a loss of €1,401.
Where can I find the annual accounts of S.C. Pharma?
S.C. Pharma filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of S.C. Pharma due?
S.C. Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.